BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

935 related articles for article (PubMed ID: 28738457)

  • 1. [Survey of economic burden of hepatitis B-related diseases in 12 areas in China].
    Ma QS; Liang S; Xiao HW; Zhang SX; Zhuang GH; Zou YH; Tan HZ; Liu JC; Zhang YH; Xu AQ; Zhang L; Feng XX; Hu DS; Wang FZ; Cui FQ; Liang XF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):868-876. PubMed ID: 28738457
    [No Abstract]   [Full Text] [Related]  

  • 2. [Financial burden of hepatitis B-related diseases and factors influencing the costs in Shenzhen, China].
    Liang S; Zhang SX; Ma QS; Xiao HW; Lü QY; Xie X; Mei SJ; Hu DS; Zhou BP; Li B; Chen JF; Cui FQ; Wang FZ; Liang XF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1340-5. PubMed ID: 21223660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Economic burden of hepatitis C patients and related influencing factors in Guangdong province].
    Wu QM; Li Y; Fu XB; Yang F; Li J; Huang HZ; Yan J; Lin P
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jul; 39(7):931-936. PubMed ID: 30060307
    [No Abstract]   [Full Text] [Related]  

  • 4. Direct economic burden of hepatitis B virus related diseases: evidence from Shandong, China.
    Lu J; Xu A; Wang J; Zhang L; Song L; Li R; Zhang S; Zhuang G; Lu M
    BMC Health Serv Res; 2013 Jan; 13():37. PubMed ID: 23368750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Financial burden on the families of patients with hepatitis B virus-related liver diseases and the role of public health insurance in Yunnan province of China.
    Che YH; Chongsuvivatwong V; Li L; Sriplung H; Wang YY; You J; Ma SJ; Yan Y; Zhang RY; Shen T; Chen HM; Rao SF; Zhang XL
    Public Health; 2016 Jan; 130():13-20. PubMed ID: 25931438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of total economic burden of chronic hepatitis B (CHB)-related diseases in Beijing and Guangzhou, China.
    Hu M; Chen W
    Value Health; 2009; 12 Suppl 3():S89-92. PubMed ID: 20586991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Economic burden and related factors on inpatients with HBV-related diseases in Shandong province].
    Lü JJ; Li RP; Xu AQ; Zhang L; Song LZ; Yan BY; Ji F; Liu JY; Fang XQ; Wang Z; Zhu DW; Zhang GJ; Feng Y; Xiao ZK; Wang J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Mar; 34(3):267-72. PubMed ID: 23759235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Estimation on the intangible cost and influencing factors for patients with hepatitis B-related diseases].
    Ma QS; Zou YH; Zhang SX; Liang S; Xiao HW; Xie X; Mei SJ; Jia WD; Zhang YF; Cui FQ; Wang FZ; Liang XF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Aug; 32(8):764-7. PubMed ID: 22093463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Economic burden of esophageal cancer in China from 1996 to 2015: a systematic review].
    Guo LW; Shi CL; Huang HY; Wang L; Yue XP; Liu SZ; Li J; Su K; Dai M; Sun XB; Shi JF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jan; 38(1):102-109. PubMed ID: 28100387
    [No Abstract]   [Full Text] [Related]  

  • 10. Annual economic burden of hepatitis B virus-related diseases among hospitalized patients in twelve cities in China.
    Zhang S; Ma Q; Liang S; Xiao H; Zhuang G; Zou Y; Tan H; Liu J; Zhang Y; Zhang L; Feng X; Xue L; Hu D; Cui F; Liang X
    J Viral Hepat; 2016 Mar; 23(3):202-10. PubMed ID: 26663525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs of chronic obstructive pulmonary disease in urban areas of China: a cross-sectional study in four cities.
    Chen X; Wang N; Chen Y; Xiao T; Fu C; Xu B
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2625-2632. PubMed ID: 27799761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on economic burden caused by antiretroviral treatment for people living with HIV/AIDS and influencing factors in Nanjing].
    Zhang X; Li M; Feng Y; Bu K; Fu G; Liu X; Chen Y; Shi L; Bai C; Wei H; Huan X; Wang L
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 May; 36(5):440-4. PubMed ID: 26080630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inpatient care burden due to cancers in Anhui, China: a cross-sectional household survey.
    Zhao T; Cheng J; Chai J; Feng R; Liang H; Shen X; Sha R; Wang D
    BMC Public Health; 2016 Apr; 16():308. PubMed ID: 27067524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of economic outcomes of "hepatitis B vaccine event reported by media" in China, 2013].
    Zhang SX; Sun PP; Xia Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Aug; 52(8):837-841. PubMed ID: 30107719
    [No Abstract]   [Full Text] [Related]  

  • 15. Mental health inpatient treatment expenditure trends in China, 2005-2012: evidence from Shandong.
    Xu J; Wang J; Liu R; Xing J; Su L; Yu F; Lu M
    J Ment Health Policy Econ; 2014 Dec; 17(4):173-82. PubMed ID: 25599281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A cross-sectional study on economic burden of pulmonary tuberculosis cases from designated tuberculosis hospital].
    Liu Y; Xu CH; Wang ZY; Wang XM; Wang YH; Zhang H; Wang L
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 May; 40(5):559-564. PubMed ID: 31177738
    [No Abstract]   [Full Text] [Related]  

  • 17. [Trend in medical expenditures for patients with kidney diseases: An analysis from a tertiary hospital in Beijing].
    Bi SH; Li ZF; Wang T; Wang Y; Zhang C; Ji H; Shi J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Nov; 53(1):215-219. PubMed ID: 33550360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis on direct economic burden of stroke in the rural population of Hanzhong, Shaanxi Province].
    Long Y; Lu J; Xu DZ; Hu JX; Jiang JH; Yan YP; Huang JY; Yang J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Jul; 26(7):494-7. PubMed ID: 16334999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cost-effectiveness of community-based treatment of chronic hepatitis B in China].
    Zhang SX; Yang PC; Cai YL; Lin Y; Zou YH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):860-867. PubMed ID: 28738456
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cost-effectiveness and affordability of strategy for preventing mother-to-child transmission of hepatitis B in China].
    Lin Y; Zhang SX; Yang PC; Cai YL; Zou YH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):852-859. PubMed ID: 28738455
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 47.